Karen Eberle

603 total citations
26 papers, 476 citations indexed

About

Karen Eberle is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Karen Eberle has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Karen Eberle's work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (8 papers) and Antimicrobial Peptides and Activities (3 papers). Karen Eberle is often cited by papers focused on Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (8 papers) and Antimicrobial Peptides and Activities (3 papers). Karen Eberle collaborates with scholars based in United States, United Kingdom and China. Karen Eberle's co-authors include Glen E. Palmer, Hong Xin, Douglas A. Johnston, Marion S. Freistadt, Elias Klein, Paul L. Fidel, Brian M. Peters, Junko Yano, Thomas J. Vogl and Andrew N. J. McKenzie and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Karen Eberle

26 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Eberle United States 13 249 171 115 55 53 26 476
Ana Camila Oliveira Souza United States 15 347 1.4× 279 1.6× 143 1.2× 46 0.8× 114 2.2× 25 608
Hidenori Kaminishi Japan 14 352 1.4× 191 1.1× 233 2.0× 47 0.9× 57 1.1× 38 718
Jianfeng Lin United States 17 258 1.0× 321 1.9× 224 1.9× 33 0.6× 67 1.3× 37 764
Filipe Cerca Portugal 9 200 0.8× 85 0.5× 324 2.8× 131 2.4× 42 0.8× 10 525
Nikki J. Wagner United States 15 166 0.7× 207 1.2× 229 2.0× 122 2.2× 162 3.1× 26 780
Michelle J. Henry‐Stanley United States 19 320 1.3× 185 1.1× 346 3.0× 87 1.6× 68 1.3× 37 909
Jiqin Wu China 14 344 1.4× 271 1.6× 94 0.8× 20 0.4× 28 0.5× 28 617
Josie F. Gibson United Kingdom 8 202 0.8× 126 0.7× 199 1.7× 83 1.5× 129 2.4× 9 490
Jun-Hong Ch’ng Singapore 14 150 0.6× 98 0.6× 252 2.2× 62 1.1× 74 1.4× 22 721
Liqi Zhu China 17 260 1.0× 123 0.7× 214 1.9× 20 0.4× 97 1.8× 42 763

Countries citing papers authored by Karen Eberle

Since Specialization
Citations

This map shows the geographic impact of Karen Eberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Eberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Eberle more than expected).

Fields of papers citing papers by Karen Eberle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Eberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Eberle. The network helps show where Karen Eberle may publish in the future.

Co-authorship network of co-authors of Karen Eberle

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Eberle. A scholar is included among the top collaborators of Karen Eberle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Eberle. Karen Eberle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eberle, Karen, et al.. (2025). Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates. iScience. 28(5). 112459–112459. 1 indexed citations
2.
Mao, Changchuin, Karen Eberle, Xiaojie Chen, et al.. (2024). FcRider: a recombinant Fc nanoparticle with endogenous adjuvant activities for hybrid immunization. PubMed. 7(4). 295–306. 1 indexed citations
3.
Huang, Wei‐Chiao, et al.. (2024). Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis. mSphere. 9(7). e0018924–e0018924. 5 indexed citations
4.
Eberle, Karen, et al.. (2021). Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans. Vaccine. 39(30). 4099–4107. 12 indexed citations
5.
Xin, Hong, et al.. (2019). Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis. Vaccine. 37(18). 2430–2438. 12 indexed citations
6.
Xin, Hong, et al.. (2019). Experimental Mouse Models of Disseminated Candida auris Infection. mSphere. 4(5). 47 indexed citations
7.
Butts, Arielle, Tracy L. Peters, Josie E. Parker, et al.. (2017). Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. mSphere. 2(5). 11 indexed citations
8.
Tournu, Hélène, Jennifer L. Carroll, Brian Latimer, et al.. (2017). Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans. PLoS ONE. 12(2). e0171145–e0171145. 11 indexed citations
9.
Peters, Brian M., Karen Eberle, Timothy P. Foster, et al.. (2015). ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis. Eukaryotic Cell. 14(10). 1006–1016. 28 indexed citations
10.
Eberle, Karen, et al.. (2015). Trafficking through the Late Endosome Significantly Impacts Candida albicans Tolerance of the Azole Antifungals. Antimicrobial Agents and Chemotherapy. 59(4). 2410–2420. 19 indexed citations
11.
12.
Eberle, Karen, et al.. (2011). Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB. PLoS ONE. 6(6). e21496–e21496. 37 indexed citations
13.
Johnston, Douglas A., Karen Eberle, Joy Sturtevant, & Glen E. Palmer. (2009). Role for Endosomal and Vacuolar GTPases in Candida albicans Pathogenesis. Infection and Immunity. 77(6). 2343–2355. 27 indexed citations
14.
Khan, Imtiaz A., et al.. (2008). Coinfection with Heligmosomoides polygyrus Fails To Establish CD8 + T-Cell Immunity against Toxoplasma gondii. Infection and Immunity. 76(5). 2256–2256. 1 indexed citations
15.
Khan, Imtiaz A., et al.. (2008). Coinfection withHeligmosomoides polygyrusFails To Establish CD8+T-Cell Immunity againstToxoplasma gondii. Infection and Immunity. 76(3). 1305–1313. 34 indexed citations
16.
Freistadt, Marion S. & Karen Eberle. (2007). Conserved aspartic acid 233 and alanine 231 are not required for poliovirus polymerase function in replicons. Virology Journal. 4(1). 28–28. 2 indexed citations
17.
Freistadt, Marion S., et al.. (2007). Biochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase. Virology Journal. 4(1). 44–44. 28 indexed citations
18.
Freistadt, Marion S., David A. Stoltz, & Karen Eberle. (1995). Role of Poliovirus Receptors in the Spread of the Infection. Annals of the New York Academy of Sciences. 753(1). 37–47. 7 indexed citations
19.
Srinivasan, Sathanur R., Parakat Vijayagopal, Karen Eberle, et al.. (1988). Low density lipoprotein binding affinity of arterial wall isomeric chondroitin sulfate proteoglycans. Atherosclerosis. 72(1). 1–9. 16 indexed citations
20.
Srinivasan, S. R., Karen Eberle, H. Ruiz, et al.. (1988). Composition of proteoglycans synthesized by rabbit aortic explants in culture and the effect of experimental atherosclerosis. Biochimica et Biophysica Acta (BBA) - General Subjects. 964(2). 231–243. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Camila Oliveira Souza Breakdown of academic impact, for papers by Hidenori Kaminishi Breakdown of academic impact, for papers by Jianfeng Lin Breakdown of academic impact, for papers by Filipe Cerca Breakdown of academic impact, for papers by Nikki J. Wagner Breakdown of academic impact, for papers by Michelle J. Henry‐Stanley Breakdown of academic impact, for papers by Jiqin Wu Breakdown of academic impact, for papers by Josie F. Gibson Breakdown of academic impact, for papers by Jun-Hong Ch’ng Breakdown of academic impact, for papers by Liqi Zhu
Rankless by CCL
2026